Abstract
Introduction
The aim of this study was to report the long-term follow-up results of cryoballoon (CB) ablation in patients with atrial fibrillation.
Methods
All consecutive patients who underwent second-generation CB ablation from February 2015 to December 2017 were included in our study. In all procedures, we used a 28-mm CB placed via a single transseptal puncture guided by intracardiac ultrasound. A 20-mm octapolar intraluminal circular catheter was used for intracardiac recordings. A single 180-s freeze strategy was employed. Repeated procedures were performed with a 3D map** system and radiofrequency catheters.
Results
A total of 126 patients (69.8% male, mean age 57 ± 11 years), of which 77.0% had paroxysmal atrial fibrillation (PAF), were included in the study. After a 5-year period, 52.4% of patients were in sinus rhythm without AF recurrence, off antiarrhythmic drugs. A total of 61.9% of patients were free of AF recurrence when redo PVI procedures were performed. When accounting for redo pulmonary vein isolation and antiarrhythmic drugs, a total of 73.8% of the patients were without AF recurrence in long-term follow-up. The patients who underwent redo pulmonary vein isolation procedures had statistically significant lower rates of AF recurrence (p = 0.006). In patients with PAF, long-term success rates improved from 62.9 to 79.4% for patients who underwent the redo procedure (p = 0.020). In patients with persistent atrial fibrillation (PersAF), success rates went up from 41.4 to 55.1% for patients with single or repeated PVI procedure (p = 0.071). In the whole cohort, a total of 3 (2.4%) procedure-related major complications occurred which included persistent PNP, arterial pseudoaneurysm, and arteriovenous fistula.
Conclusion
Our data suggest a favorable long-term safety and efficacy profile of second-generation CB ablation. In the mixed paroxysmal and persistent population, up to 73.8% of patients remained free of AF recurrence in the 5-year follow-up, when accounting for redo procedures and AADs. Only 2.4% of patients experienced major complications of the ablation procedure, none with permanent sequelae.
Graphical Abstract
Similar content being viewed by others
Data availability
No associated data.
References
Metzner A, Reissmann B, Rausch P, Mathew S, Wohlmuth P, Tilz R, et al. One-year clinical outcome after pulmonary vein isolation using the second-generation 28-mm cryoballoon. Circ Arrhythm Electrophysiol. 2014;7(2):288–92. https://doi.org/10.1161/CIRCEP.114.001473.
Wissner E, Heeger CH, Grahn H, Reissmann B, Wohlmuth P, Lemes C, et al. One-year clinical success of a ‘no-bonus’ freeze protocol using the second-generation 28 mm cryoballoon for pulmonary vein isolation. Europace. 2015;17(8):1236–40. https://doi.org/10.1093/europace/euv024.
Heeger CH, Wissner E, Knöll M, Knoop B, Reissmann B, Mathew S, et al. Three-year clinical outcome after 2nd-generation cryoballoon-based pulmonary vein isolation for the treatment of paroxysmal and persistent atrial fibrillation - a 2-center experience. Circ J. 2017;81(7):974–80. https://doi.org/10.1253/circj.CJ-16-1334.
Gökoğlan Y, Mohanty S, Güneş MF, Trivedi C, Santangeli P, Gianni C, et al. Pulmonary vein antrum isolation in patients with paroxysmal atrial fibrillation: more than a decade of follow-up. Circ Arrhythm Electrophysiol. 2016;9(5):e003660. https://doi.org/10.1161/CIRCEP.115.003660.
Ouyang F, Tilz R, Chun J, Schmidt B, Wissner E, Zerm T, et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation. 2010;122(23):2368–77. https://doi.org/10.1161/CIRCULATIONAHA.110.946806.
Uchiyama T, Miyazaki S, Taniguchi H, Komatsu Y, Kusa S, Nakamura H, et al. Six-year follow-up of catheter ablation in paroxysmal atrial fibrillation. Circ J. 2013;77(11):2722–7. https://doi.org/10.1253/circj.cj-13-0468.
Sawhney N, Anousheh R, Chen WC, Narayan S, Feld GK. Five-year outcomes after segmental pulmonary vein isolation for paroxysmal atrial fibrillation. Am J Cardiol. 2009;104(3):366–72. https://doi.org/10.1016/j.amjcard.2009.03.044.
Sorgente A, Tung P, Wylie J, Josephson ME. Six year follow-up after catheter ablation of atrial fibrillation: a palliation more than a true cure. Am J Cardiol. 2012;109(8):1179–86. https://doi.org/10.1016/j.amjcard.2011.11.058.
Chierchia GB, Di Giovanni G, Ciconte G, de Asmundis C, Conte G, Sieira-Moret J, et al. Second-generation cryoballoon ablation for paroxysmal atrial fibrillation: 1-year follow-up. Europace. 2014;16(5):639–44. https://doi.org/10.1093/europace/eut417.
Scherr D, Khairy P, Miyazaki S, Aurillac-Lavignolle V, Pascale P, Wilton SB, et al. Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint. Circ Arrhythm Electrophysiol. 2015;8(1):18–24. https://doi.org/10.1161/CIRCEP.114.001943.
Schreiber D, Rostock T, Fröhlich M, Sultan A, Servatius H, Hoffmann BA, et al. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success. Circ Arrhythm Electrophysiol. 2015;8(2):308–17. https://doi.org/10.1161/CIRCEP.114.001672.
Tilz RR, Heeger CH, Wick A, Saguner AM, Metzner A, Rillig A, et al. Ten-year clinical outcome after circumferential pulmonary vein isolation utilizing the Hamburg approach in patients with symptomatic drug-refractory paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol. 2018;11(2):e005250. https://doi.org/10.1161/CIRCEP.117.005250.
Ciconte G, Ottaviano L, de Asmundis C, Baltogiannis G, Conte G, Sieira J, et al. Pulmonary vein isolation as index procedure for persistent atrial fibrillation: one-year clinical outcome after ablation using the second-generation cryoballoon. Heart Rhythm. 2015;12(1):60–6. https://doi.org/10.1016/j.hrthm.2014.09.063.
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al.; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. https://doi.org/10.1093/eurheartj/ehaa612. Erratum in: Eur Heart J. 2021;42(5):507. Erratum in: Eur Heart J. 2021;42(5):546–547. Erratum in: Eur Heart J. 2021;42(40):4194.
Ciconte G, Mugnai G, Sieira J, Velagić V, Saitoh Y, Irfan G, et al. On the quest for the best freeze: predictors of late pulmonary vein reconnections after second-generation cryoballoon ablation. Circ Arrhythm Electrophysiol. 2015;8(6):1359–65. https://doi.org/10.1161/CIRCEP.115.002966.
Ghosh J, Singarayar S, Kabunga P, McGuire MA. Subclavian vein pacing and venous pressure waveform measurement for phrenic nerve monitoring during cryoballoon ablation of atrial fibrillation. Europace. 2015;17(6):884–90. https://doi.org/10.1093/europace/euu341.
Kuniss M, Pavlovic N, Velagic V, Hermida JS, Healey S, Arena G, et al. Cryo-FIRST Investigators. Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation. Europace. 2021;23(7):1033–41. https://doi.org/10.1093/europace/euab029.
Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, et al. FIRE AND ICE Investigators. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374(23):2235–45. https://doi.org/10.1056/NEJMoa1602014.
Hoffmann E, Straube F, Wegscheider K, Kuniss M, Andresen D, Wu LQ, et al. FREEZE Cohort Study Investigators. Outcomes of cryoballoon or radiofrequency ablation in symptomatic paroxysmal or persistent atrial fibrillation. Europace. 2019;21(9):1313–24. https://doi.org/10.1093/europace/euz155.
Ganesan AN, Shipp NJ, Brooks AG, Kuklik P, Lau DH, Lim HS, et al. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2(2):e004549. https://doi.org/10.1161/JAHA.112.004549.
Ngo L, Lee XW, Elwashahy M, Arumugam P, Yang IA, Denman R, et al. Freedom from atrial arrhythmia and other clinical outcomes at 5 years and beyond after catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes. 2023;9(5):447–58. https://doi.org/10.1093/ehjqcco/qcad037.
Winkle RA, Mead RH, Engel G, Salcedo J, Brodt C, Barberini P, et al. Very long term outcomes of atrial fibrillation ablation. Heart Rhythm. 2023;20(5):680–8. https://doi.org/10.1016/j.hrthm.2023.02.002.
Akkaya E, Berkowitsch A, Zaltsberg S, Greiss H, Hamm CW, Sperzel J, et al. Five-year outcome and predictors of success after second-generation cryoballoon ablation for treatment of symptomatic atrial fibrillation. Int J Cardiol. 2018;266:106–11. https://doi.org/10.1016/j.ijcard.2018.03.069.
Heeger CH, Subin B, Wissner E, Fink T, Mathew S, Maurer T, et al. Second-generation cryoballoon-based pulmonary vein isolation: lessons from a five-year follow-up. Int J Cardiol. 2020;312:73–80. https://doi.org/10.1016/j.ijcard.2020.03.062.
Mugnai G, Paparella G, Overeinder I, Ströker E, Sieira J, Bisignani A, et al. Long-term clinical outcomes after single freeze cryoballoon ablation for paroxysmal atrial fibrillation: a 5-year follow-up. J Interv Card Electrophysiol. 2021;61(1):87–93. https://doi.org/10.1007/s10840-020-00788-w.
Davies AJ, Jackson N, Barlow M, Leitch J. Long term follow-up of pulmonary vein isolation using cryoballoon ablation. Heart Lung Circ. 2016;25(3):290–5. https://doi.org/10.1016/j.hlc.2015.07.012.
Koopman P, Bekelaar T, Schurmans J, Phlips T, Dilling-Boer D, Vijgen J. Pulmonary vein isolation by visually guided laser balloon ablation: single-center 5-year follow-up results. J Interv Card Electrophysiol. 2023;66(9):2081–9. https://doi.org/10.1007/s10840-023-01544-6.
Andrade JG, Deyell MW, Macle L, Wells GA, Bennett M, Essebag V, et al. EARLY-AF Investigators. Progression of atrial fibrillation after cryoablation or drug therapy. N Engl J Med. 2023;388(2):105–16. https://doi.org/10.1056/NEJMoa2212540.
Mugnai G, Irfan G, de Asmundis C, Ciconte G, Saitoh Y, Hunuk B, et al. Complications in the setting of percutaneous atrial fibrillation ablation using radiofrequency and cryoballoon techniques: a single-center study in a large cohort of patients. Int J Cardiol. 2015;196:42–9. https://doi.org/10.1016/j.ijcard.2015.05.145.
Bollmann A, Ueberham L, Schuler E, Wiedemann M, Reithmann C, Sause A, et al. Cardiac tamponade in catheter ablation of atrial fibrillation: German-wide analysis of 21 141 procedures in the Helios atrial fibrillation ablation registry (SAFER). Europace. 2018;20(12):1944–51. https://doi.org/10.1093/europace/euy131.
Straube F, Dorwarth U, Pongratz J, Brück B, Wankerl M, Hartl S, et al. The fourth cryoballoon generation with a shorter tip to facilitate real-time pulmonary vein potential recording: feasibility and safety results. J Cardiovasc Electrophysiol. 2019;30(6):918–25. https://doi.org/10.1111/jce.13927.
Saitoh Y, Ströker E, Irfan G, Mugnai G, Ciconte G, Hünük B, et al. Fluoroscopic position of the second-generation cryoballoon during ablation in the right superior pulmonary vein as a predictor of phrenic nerve injury. Europace. 2016;18(8):1179–86. https://doi.org/10.1093/europace/euv362.
Tilz RR, Schmidt V, Pürerfellner H, Maury P, Chun KRJU, Martinek M, et al. A worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF study. Eur Heart J. 2023;44(27):2458–69. https://doi.org/10.1093/eurheartj/ehad250.
D’Ascenzo F, Corleto A, Biondi-Zoccai G, Anselmino M, Ferraris F, di Biase L, et al. Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation?: a meta-analysis. Int J Cardiol. 2013;167(5):1984–9. https://doi.org/10.1016/j.ijcard.2012.05.008.
Jalife J, Kaur K. Atrial remodeling, fibrosis, and atrial fibrillation. Trends Cardiovasc Med. 2015;25(6):475–84. https://doi.org/10.1016/j.tcm.2014.12.015.
Mugnai G, Chierchia GB, de Asmundis C, Juliá J, Conte G, Sieira-Moret J, et al. P-wave indices as predictors of atrial fibrillation recurrence after pulmonary vein isolation in normal left atrial size. J Cardiovasc Med (Hagerstown). 2016;17(3):194–200. https://doi.org/10.2459/JCM.0000000000000220.
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C,et al.; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. https://doi.org/10.1093/eurheartj/ehaa612. Erratum in: Eur Heart J. 2021;42(5):507. Erratum in: Eur Heart J. 2021 Feb 1;42(5):546–7. Erratum in: Eur Heart J. 2021;42(40):4194.
Wokhlu A, Hodge DO, Monahan KH, Asirvatham SJ, Friedman PA, Munger TM, et al. Long-term outcome of atrial fibrillation ablation: impact and predictors of very late recurrence. J Cardiovasc Electrophysiol. 2010;21(10):1071–8. https://doi.org/10.1111/j.1540-8167.2010.01786.x.
Miyazaki S, Kuwahara T, Kobori A, Takahashi Y, Takei A, Sato A, et al. Preprocedural predictors of atrial fibrillation recurrence following pulmonary vein antrum isolation in patients with paroxysmal atrial fibrillation: long-term follow-up results. J Cardiovasc Electrophysiol. 2011;22(6):621–5. https://doi.org/10.1111/j.1540-8167.2010.01984.x.
Mugnai G, de Asmundis C, Hünük B, Ströker E, Moran D, et al. Improved visualisation of real-time recordings during third generation cryoballoon ablation: a comparison between the novel short-tip and the second generation device. J Interv Card Electrophysiol. 2016;46(3):307–14. https://doi.org/10.1007/s10840-016-0114-9.
Moltrasio M, Sicuso R, Fassini GM, Riva SI, Tundo F, Dello Russo A, Casella M, Majocchi B, Zucchetti M, Cellucci S, Tondo C. Acute outcome after a single cryoballoon ablation: comparison between Arctic Front Advance and Arctic Front Advance PRO. Pacing Clin Electrophysiol. 2019;42(7):890–6. https://doi.org/10.1111/pace.13718.
Anic A, Lever N, Martin A, Breskovic T, Sulkin MS, Duffy E, et al. Acute safety, efficacy, and advantages of a novel cryoballoon ablation system for pulmonary vein isolation in patients with paroxysmal atrial fibrillation: initial clinical experience. Europace. 2021;23(8):1237–43. https://doi.org/10.1093/europace/euab018.
Martin A, Fowler M, Breskovic T, Ouss A, Dekker L, Yap SC, et al. Novel cryoballoon to isolate pulmonary veins in patients with paroxysmal atrial fibrillation: long-term outcomes in a multicentre clinical study. J Interv Card Electrophysiol. 2022;65(3):609–16. https://doi.org/10.1007/s10840-022-01200-5.
Tanese N, Almorad A, Pannone L, Defaye P, Jacob S, Kilani MB, et al. Outcomes after cryoballoon ablation of paroxysmal atrial fibrillation with the PolarX or the Arctic Front Advance Pro: a prospective multicentre experience. Europace. 2023;25(3):873–9. https://doi.org/10.1093/europace/euad005.
Assaf A, Bhagwandien RE, Szili-Torok T, Yap SC. Comparison of the acute outcome of two cryoballoon technologies for pulmonary vein isolation: an updated systematic review and meta-analysis. Int J Cardiol Heart Vasc. 2022;5(42):101115. https://doi.org/10.1016/j.ijcha.2022.101115.
Su WW, Mittal S, Varma N, Aryana A, Marrouche NF, Anic A, Nair DG. Clinical application of a novel 31mm cryoballoon for pulmonary vein isolation for paroxysmal atrial fibrillation: procedural data from the fit arm of frozen AF. Heart Rhythm. 2023;20:5S. https://doi.org/10.1016/j.hrthm.2023.03.560.
Author information
Authors and Affiliations
Contributions
AN and VV were responsible for conception of the study and drafting of the manuscript. VP, IP, BPN, JEB, JPP, DK, ZK, and AS were responsible for acquisition and analysis of the data. DP, CdA, GBC, and DM were responsible for critical revision of the manuscript and important intellectual content.
Corresponding author
Ethics declarations
Ethics approval
Ethical approval was waived by the local Ethics Committee of University Hospital Centre Zagreb in view of the retrospective nature of the study and all the procedures being performed were part of the routine care. The protocol was carried out in accordance with the ethical principles for medical research involving human subjects established by Helsinki’s declaration, protecting the privacy of all the participants as well as the confidentiality of their personal information.
Conflict of interest
VV received proctoring and lecture fees from Medtronic, Biosense-Webster, Abbott, and Boston Scientific; GBC and CdA received compensation for teaching purposes and proctoring from Medtronic, Acutus Medical, Biosense-Webster, Biotronik, Abbott Medical, Boston Scientific, and Philips. All other authors have no financial interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Nekić, A., Prepolec, I., Pašara, V. et al. Treatment of atrial fibrillation with second-generation cryoballoon followed by contact-sensing radiofrequency catheter ablation for arrhythmia recurrences—results of a 5-year follow-up. J Interv Card Electrophysiol (2024). https://doi.org/10.1007/s10840-024-01752-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10840-024-01752-8